Miyazaki, Kazuhito
Yoshimura, Yukihiro
Miyata, Nobuyuki
Sasaki, Hiroaki
Shiba, Aya
Aga, Masaharu
Hamakawa, Yusuke
Taniguchi, Yuri
Misumi, Yuki
Agemi, Yoko
Shimokawa, Tsuneo
Okamoto, Hiroaki
Tachikawa, Natsuo
Article History
Received: 23 September 2021
Accepted: 17 March 2022
First Online: 29 March 2022
Competing interests
: The authors (K.M., Y.Y., N.M., H.S., N.T.) received research funding from three companies, Gilead Sciences, Inc., Eli Lilly Japan K.K, and Ono Pharmaceutical Co., Ltd., in the last three years from organizations that may have an interest in the submitted work; no other relationships or activities that could appear to have influenced the submitted work exist. The remaining authors (A.S., M.A., Y.H., Y.T., Y.M., Y.A., T.S., and H.O.) declare no conflicts of interest or other disclosures.